KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetShares Repurchased
Ratios

AbbVie (ABBV) Receivables - Net (2016 - 2025)

AbbVie (ABBV) has disclosed Receivables - Net for 14 consecutive years, with $12.6 billion as the latest value for Q4 2025.

  • On a quarterly basis, Receivables - Net rose 15.29% to $12.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $12.6 billion, a 15.29% increase, with the full-year FY2025 number at $12.6 billion, up 15.29% from a year prior.
  • Receivables - Net was $12.6 billion for Q4 2025 at AbbVie, down from $12.8 billion in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $12.8 billion in Q3 2025 to a low of $9.3 billion in Q3 2021.
  • A 5-year average of $11.2 billion and a median of $11.3 billion in 2022 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: soared 50.71% in 2021, then decreased 2.12% in 2024.
  • AbbVie's Receivables - Net stood at $10.0 billion in 2021, then rose by 12.8% to $11.3 billion in 2022, then dropped by 0.88% to $11.2 billion in 2023, then dropped by 2.12% to $10.9 billion in 2024, then grew by 15.29% to $12.6 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Receivables - Net are $12.6 billion (Q4 2025), $12.8 billion (Q3 2025), and $12.6 billion (Q2 2025).